enVVeno Medical Corporation
NVNO | NASDAQ
$8.86
-$0.19 (-2.10%)
Sep 22, 2026, 12:19 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 237K | 367K | 489K | 494K | 503K | 509K | 528K | 540K | 549K | 551K | 546K | 542K | 537K | 532K | 525K | 516.59K | 503.73K | 478.23K | 452.91K | 427.3K | 405.7K | 401.59K |
Gross Profit | -237K | -367K | -489K | -494K | -503K | -509K | -528K | -540K | -549K | -551K | -546K | -542K | -537K | -532K | -525K | -516.59K | -503.73K | -478.23K | -452.91K | -427.3K | -405.7K | -401.59K |
Operating Income | -16.75M | -20.01M | -20.9M | -23.59M | -24.87M | -23.28M | -23.83M | -23.41M | -22.58M | -23.94M | -25.24M | -25.42M | -26.22M | -26.39M | -24.93M | -27.46M | -24.02M | -19.42M | -16.89M | -12.06M | -11.27M | -10.43M |
Interest Income | 309K | 495K | 692K | 752K | 671K | 549K | 389K | 278K | 228K | 194K | 180K | 172K | 203K | 201K | 161K | 121.53K | 51.05K | 20.75K | 18.71K | 14.5K | 10.54K | 4.07K |
Pretax Income | -15.72M | -18.82M | -19.47M | -21.97M | -23.07M | -21.33M | -21.82M | -21.24M | -20.6M | -22.12M | -23.52M | -24.05M | -25.14M | -25.73M | -24.67M | -27.48M | -23.77M | -19.09M | -16.53M | -11.91M | -11.5M | -10.75M |
Net Income | -15.72M | -18.82M | -19.47M | -21.97M | -23.07M | -21.33M | -21.82M | -21.24M | -20.6M | -22.12M | -23.52M | -24.05M | -25.14M | -25.73M | -24.67M | -27.48M | -23.77M | -19.08M | -16.53M | -11.91M | -11.5M | -10.75M |
Selling & General & Admin | 7.8M | 10.1M | 10.43M | 11.54M | 12.55M | 11.01M | 11.05M | 11.15M | 10.38M | 10.35M | 11.1M | 11.47M | 12.59M | 13.91M | 14.49M | 18.05M | 15.88M | 13.29M | 10.71M | 5.41M | 5.11M | 4.66M |
Research & Development | 8.72M | 9.54M | 9.98M | 11.55M | 11.82M | 11.75M | 12.25M | 11.72M | 11.66M | 13.05M | 13.59M | 13.4M | 13.1M | 11.96M | 9.91M | 8.9M | 7.63M | 5.65M | 5.73M | 6.22M | 5.76M | 5.37M |
Other Expenses | n/a | 1 | 1 | 1 | 1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.52M | 19.64M | 20.41M | 23.09M | 24.37M | 22.77M | 23.3M | 22.87M | 22.04M | 23.39M | 24.69M | 24.88M | 25.69M | 25.86M | 24.41M | 26.95M | 23.52M | 18.94M | 16.44M | 11.63M | 10.87M | 10.03M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 16.75M | 20.01M | 20.9M | 23.59M | 24.87M | 23.28M | 23.83M | 23.41M | 22.58M | 23.94M | 25.24M | 25.42M | 26.22M | 26.39M | 24.93M | 27.46M | 24.02M | 19.42M | 16.89M | 12.06M | 11.27M | 10.43M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 671K | 654K | 632.24K | 575.86K | 581.49K | 581.49K | 501.03K | 459.06K | 459.06K | 458.77K | 380.49K | 320.89K | 320.89K | 320.89K | 270.63K | 320.83K | 320.83K | 320.83K | 270.57K | 262.27K | 243.2K | 164.03K |
Shares Outstanding (Diluted) | 671K | 654K | 16.45K | 16.45K | 16.61K | 16.61K | 16.64K | 13.12K | 13.12K | 13.11K | 10.87K | 9.17K | 9.17K | 9.17K | 7.73K | 9.17K | 9.17K | 9.17K | 9.14K | 7.49K | 6.95K | 4.69K |
EPS (Basic) | -520.08 | -918.96 | -1.18K | -1.34K | -1.48K | -1.46K | -1.57K | -1.7K | -1.83K | -2.16K | -2.47K | -2.76K | -2.87K | -2.93K | -2.81K | -2.99K | -2.65K | -2.22K | -2.23K | -3.79K | -5.16K | -7.13K |
EPS (Diluted) | -520.08 | -918.96 | -1.18K | -1.34K | -1.48K | -1.46K | -1.57K | -1.7K | -1.83K | -2.16K | -2.47K | -2.76K | -2.87K | -2.93K | -2.81K | -2.99K | -2.65K | -2.22K | -2.23K | -3.79K | -5.16K | -7.13K |
EBITDA | -15.58M | -18.54M | -18.98M | -21.47M | -22.57M | -20.82M | -21.29M | -20.7M | -20.05M | -21.57M | -22.97M | -23.51M | -24.61M | -25.2M | -24.14M | -26.96M | -23.27M | -18.61M | -16.07M | -11.27M | -10.88M | -10.13M |
EBIT | -15.94M | -19.03M | -19.47M | -21.97M | -23.07M | -21.33M | -21.82M | -21.24M | -20.6M | -22.12M | -23.52M | -24.05M | -25.14M | -25.73M | -24.67M | -27.48M | -23.77M | -19.08M | -16.53M | -11.7M | -11.28M | -10.53M |
Depreciation & Amortization | 361K | 491K | 489K | 494K | 503K | 509K | 528K | 540K | 549K | 551K | 546K | 542K | 537K | 532K | 525K | 516.59K | 503.73K | 478.23K | 452.91K | 427.3K | 405.7K | 401.59K |
Add to Watchlist
Select watchlists to add or remove NVNO